US Stock MarketDetailed Quotes
PEN Penumbra
- 203.190
- +10.610+5.51%
Close Oct 11 16:00 ET
- 203.190
- 0.0000.00%
Post 16:01 ET
7.89BMarket Cap580.54P/E (TTM)
203.860High193.495Low387.67KVolume193.700Open192.580Pre Close78.12MTurnover1.03%Turnover Ratio87.58P/E (Static)38.84MShares277.34052wk High6.80P/B7.61BFloat Cap148.00052wk Low--Dividend TTM37.48MShs Float348.670Historical High--Div YieldTTM5.38%Amplitude35.315Historical Low201.514Avg Price1Lot Size
About Penumbra Company
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Company Profile
SymbolPEN
Company NamePenumbra
Listing DateSep 18, 2015
Issue Price30.00
Founded2004
CEOMr. Adam Elsesser
MarketNYSE
Employees4200
Fiscal Year Ends12-31
AddressOne Penumbra Place
CityAlameda
ProvinceCalifornia
CountryUnited States of America
Zip Code94502
Phone1-510-748-3200
Websitehttp://www.penumbrainc.com
Company Executives
- Name
- Position
- Salary
- Adam Elsesser
- Chief Executive Officer, President and Chairman of the Board
- 601.62K
- Maggie Yuen
- Chief Financial Officer
- 666.04K
- Lambert Shiu
- Chief Accounting Officer
- 539.94K
- Johanna Roberts
- Executive Vice President, General Counsel and Secretary
- 661.89K
- Dr. Arani Bose, M.D.
- Director
- 233.99K
- Janet Leeds
- Independent Director
- 251.49K
- Bridget O'Rourke
- Independent Director
- 263.99K
- Don Kassing
- Presiding Independent Director
- 246.49K
- Thomas C. Wilder, III
- Independent Director
- 258.99K
- Harpreet Grewal
- Independent Director
- 241.49K
- Surbhi Sarna
- Independent Director
- 248.99K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data